Gimv is a European investment company listed on Euronext Brussels with over 40 years of private equity experience. It invests directly in companies, mainly using equity on its balance sheet, across the Benelux, France, and DACH regions.
Average disclosed round size is $58.0M (across 31 rounds with reported amounts).
Portfolio
49
Fund Size
—
Top Stage
Unknown
Last 12 Mo
4
Team
Tom Van de Voorde*
Managing Partner - Head Smart Industries
Boris Wirtz
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
71 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| PPrecirix | Series B | — | Aug 2026 |
 Exciva | Series B | — | Jan 2026 |
 Kinaset Therapeutics | Series B | $103M | Jan 2026 |
| KKinaset | Series B | $103M | Jan 2026 |
| Exciva | Series B | $59M | Jan 2025 |
 Spineart | Unknown | — | Jan 2025 |
 FIRE1 | Unknown | $120M | Jan 2025 |
 KIVU BIOSCIENCE | Series A | $92M | Oct 2024 |
 ImmunOs Therapeutics | Unknown | $11M | Sep 2024 |
 ImmunOs | Series C | $11M | Sep 2024 |
 Onera Health | Series C | $32M | Jan 2024 |
 Onera | Series C | $30M | Jan 2024 |
 Complement Therapeutics | Series A | — | Apr 2023 |
| CComplement | Series A | — | Apr 2023 |
| FIRE1 | Unknown | $25M | Mar 2023 |
 Paleo | Series A | $12.7M | Feb 2023 |
 JenaValve Technology | Series C | $100M | Aug 2022 |
| JenaValve Technology | Unknown | $100M | Aug 2022 |
| IImCheck Therapeutics | Series C | — | Jun 2022 |
| ImmunOs Therapeutics | Series B | $74M | Jun 2022 |
| ImmunOs | Series B | $74M | Jun 2022 |
| PPrecirix | Series B | — | Mar 2022 |
| Complement Therapeutics | Seed | — | Feb 2022 |
| JenaValve Technology | Series C | $100M | Jan 2022 |
| PPrecirix | Seed | — | Jan 2022 |
Page 1 of 3
Top Co-Investors
EQT Life Sciences16 shared
Andera Partners12 shared
Pfizer Ventures9 shared
Cormorant Asset Management9 shared
Forbion8 shared
HealthCap8 shared
Sofinnova Partners8 shared
BioMed Ventures7 shared
Alta Partners7 shared
Atlas Venture6 shared
Novo Capital6 shared
Mission BioCapital6 shared
Abingworth LLP6 shared
Novo Holdings A/S5 shared
INKEF Capital5 shared
Vi Partners5 shared
Legend Capital5 shared
Pontifax4 shared
Jeito Capital4 shared
Last updated: 7 October 2026